Structured Summary
Abstract
A non-glycosylated form of interferon beta-1 that has a serine at position 17. It is used in the treatment of both RELAPSING-REMITTING MULTIPLE SCLEROSIS and CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
12 entry terms
- Beta-IFN-1b
- IFN-Beta Ser
- Interferon Beta, Ser(17)
- Interferon Beta, Serine(17)
- Interferon beta 1b
- Ser(17) IFN-beta
- Serine(17) Interferon Beta
- Beta-Seron
- Betaferon
- Betaseron
- Extavia
- Beta Seron
MeSH Record
Aspects Covered
30 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2016 (1985)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Interferon beta-1b. Medical Subject Headings (MeSH). 2026. Unique ID D000068576. http://id.nlm.nih.gov/mesh/2026/D000068576
- Interferon beta-1b. In: Wikipedia. https://en.wikipedia.org/wiki/Interferon_beta-1b
- Interferon beta-1b. In: Wikidata. https://www.wikidata.org/wiki/Q1851162